Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study
European Journal of Clinical Pharmacy · 20.12.2025 · 7 (1) · 6922-6927
DOI: 10.61336/ejcp/25-08-425 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 20.12.2025.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Febrile seizures are the most common seizure disorder in children, typically presenting between 6 months and 5 years of age.
Objective
To assess the clinical spectrum, associated factors, and outcomes of febrile seizures in children. Methodology: This was a hospital-based retrospective analytical study conducted at Paediatrics Department of Shahida Islam Teaching Hospital Lodhran from June, 2025 to September, 2025, including 255 pediatric patients who presented with febrile seizures.
Results
The mean age was 24.6 ± 13.2 months, with complex febrile seizures occurring at a younger age (19.8 ± 12.7 vs 26.8 ± 12.9 months, p = 0.002). Complex seizures were associated with longer duration (15.6 ± 7.8 vs 4.2 ± 2.1 minutes), higher frequency of multiple episodes (59.7% vs 15.7%), and increased focal features (48.1% vs 6.7%) (p
Zitieren
APA
(2025). Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study. European Journal of Clinical Pharmacy, 7(1), 6922-6927. https://doi.org/10.61336/ejcp/25-08-425
Vancouver
Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study. European Journal of Clinical Pharmacy. 2025;7(1):6922-6927. doi:10.61336/ejcp/25-08-425
BibTeX
@article{euvimed2025,
title = {Clinical Spectrum and Outcomes of Febrile Seizures in Children: A Retrospective Study},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {6922--6927},
doi = {10.61336/ejcp/25-08-425}
}
EUVIMED